In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • In my dark days I did not know how to explore trials for my husband. Cancer commons put me on the right path for all my options to explore. It is a load off my mind to know that I have some knowledge moving forward. Thank you for all your input!

    Cindy
    Wife of glioblastoma patient

  • Cancer Commons is such a unique concept of providing free guidance in the times that you need it the most. Having access to their expertise and knowledge is invaluable. Could not be more thankful for Cancer Commons!

    Justyna Poweska
    Wife of a brain cancer patient

  • My contact was prompt, professional, and kind. Cancer Commons helped me review my options going forward.

    Cancer patient

  • The team at Cancer Commons created a very thorough and clear report which is extremely helpful! It is evident they took the time to read my father’s medical history and suggest a personalized plan for his condition. Matt was extremely kind and supportive during this difficult time. Thank you!

    Gali
    Daughter of a glioblastoma patient

  • My family is so grateful for the information and guidance we received from Cancer Commons during a particularly stressful time where a decision needed to be made quickly. We are particularly thankful for the help and assistance of Matthew Warner…It helped give us confirmation that the trial we were looking at for my dad’s recurrent GBM was a reasonable and good decision.

    Megan
    Daughter of Glioblastoma patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.